Skip to content

Comparision of 2 different dose of elemental iron in patients with iron deficiency anemia

COMPARISON OF TWO DIFFERENT DOSES OF ELEMENTAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA (IDA) IN ADMITTED CHILDREN OF A TERTIARY CARE CENTRE IN KOLAR: AN INTERVENTIONAL STUDY - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106673
Enrollment
120
Registered
2026-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: To administer two different doses of elemental iron: Children with IDA between 1 and 5 years will be randomized into two group. group A will receive 3mg/kg/dose in two divided dose for

Sponsors

Dr Adya P Shenoy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All paediatric patients aged between 1 and 5 years of age with confirmed IDA admitted in Paediatric wards at RLJH&RC.

Exclusion criteria

Exclusion criteria: 1. Presence of chronic illnesses (chronic kidney disease, chronic liver disease, inflammatory bowel disease etc) that can affect iron metabolism. 2. Recipient of iron supplementation or blood transfusion in last 3 months. 3. Known hypersensitivity to iron preparations. 4. Active infections or sepsis that can interfere with iron metabolism.

Design outcomes

Primary

MeasureTime frame
To compare the outcome of two different doses of elemental iron in improving serum haemoglobin and ferritin levels in children admitted with IDA. To compare the frequency of side effects in both groups. Timepoint: To compare the outcome of two different doses of elemental iron in improving serum haemoglobin and ferritin levels in children admitted with IDA at 4 weeks and 3 months

Secondary

MeasureTime frame
To compare the frequency of side effects in both groups. Timepoint: To compare the frequency of side effects in both groups at 4 weeks & 3 months

Countries

India

Contacts

Public ContactDr Sudha Reddy V R

Sri Devaraj Urs Academy of Higher Education and Research

dr.sudhareddy77@gmail.com9980082440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026